Nanosphere, Inc. Logo
Nanosphere Announces Second Quarter 2011 Results
August 09, 2011 16:05 ET | Nanosphere, Inc.
NORTHBROOK, Ill., Aug. 9, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today reported financial...
Nanosphere, Inc. Logo
Nanosphere to Release Q2 2011 Results and Hold Investor Call on Tuesday, August 9
July 27, 2011 17:13 ET | Nanosphere, Inc.
NORTHBROOK, Ill., July 27, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, will report its...
Nanosphere, Inc. Logo
Nanosphere to Provide Additional Data to FDA for Verigene Clopidogrel Metabolism Nucleic Acid Test
June 21, 2011 08:00 ET | Nanosphere, Inc.
NORTHBROOK, Ill., June 21, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH) announced today it will provide additional information for its premarket approval (PMA) application following the...
Nanosphere, Inc. Logo
Nanosphere, Inc. to Present at Jefferies 2011 Global Healthcare Conference
June 03, 2011 14:24 ET | Nanosphere, Inc.
NORTHBROOK, Ill., June 3, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), announced that the company will present at the Jefferies 2011 Global Healthcare Conference on June 8. Presenting...
Nanosphere, Inc. Logo
Nanosphere to Release Positive Pilot Study Data for Ultra-Sensitive Protein Cancer Biomarkers in Conjunction With the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting
May 19, 2011 09:35 ET | Nanosphere, Inc.
NORTHBROOK, Ill., May 19, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced today that it...
Nanosphere, Inc. Logo
Positive New Data Presented at the Annual Meeting of the American Urological Association Demonstrates Clinical Use for Nanosphere's Ultra-Sensitive PSA Assay
May 18, 2011 09:37 ET | Nanosphere, Inc.
NORTHBROOK, Ill., May 18, 2011 (GLOBE NEWSWIRE) -- Positive clinical studies using Nanosphere Inc.'s (Nasdaq:NSPH) Verisens™ ultra-sensitive PSA assay (research use only) were presented in...
Nanosphere, Inc. Logo
Nanosphere, Inc. Closes Common Stock Offering
May 13, 2011 14:14 ET | Nanosphere, Inc.
NORTHBROOK, Ill., May 13, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company") (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today...
Nanosphere, Inc. Logo
Nanosphere, Inc. Prices Public Offering of Common Stock
May 10, 2011 09:00 ET | Nanosphere, Inc.
NORTHBROOK, Ill., May 10, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company") (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today...
Nanosphere, Inc. Logo
Nanosphere, Inc. Announces Commencement of Public Offering of Common Stock
May 09, 2011 16:01 ET | Nanosphere, Inc.
NORTHBROOK, Ill., May 9, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company") (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today...
Nanosphere, Inc. Logo
Nanosphere Announces First Quarter Results
April 27, 2011 07:30 ET | Nanosphere, Inc.
NORTHBROOK, Ill., April 27, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today reported...